cambridge's bluebird bio licenses delivery tech to novartis, gsk.

yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital...facebook comments.

every single pronouncement, on any subject, issued via the medical cartel�s ministry of truth would fall on disbelieving ears, and only increase general outrage...